Marianne De Backer - CEO @ Vir Biotechnology

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Primary Job Title CEO
Primary Organization
Vir Biotechnology

Location San Francisco, California, United States
Regions San Francisco Bay Area, West Coast, Western US
Gender Female

LinkedIn View on LinkedIn
X (Twitter) View on X

Marianne De Backer is the CEO of Vir Biotechnology. She previously worked at Ghent University as a Founding Board Member. Marianne De Backer attended Harvard Business School.

Jobs

Number of Current Jobs

Number of Past Jobs

Marianne De Backer

has

current jobs as

CEO

Vir Biotechnology

and

Member of the Executive Committee, EVP, Global Head Strategy, BD&L and Open Innovatio

Bayer

. Additionally,

Marianne De Backer

has had

past jobs including

Member of the Executive Committee, EVP Global Head strategy and business development

Bayer

Vir Biotechnology CEOJan 2023
Bayer Member of the Executive Committee, EVP, Global Head Strategy, BD&L and Open InnovatioJul 2021

Organization Name	Title At Company	Start Date	End Date
Bayer	Member of the Executive Committee, EVP Global Head strategy and business development	Sep 2019	Jun 2021
Johnson & Johnson	Vice President, Venture Investments, JJDC	Jan 2017	Apr 2018

Board and Advisor Roles

Number of Current Board & Advisor Roles

Marianne De Backer

holds

board and advisor roles including

Member Board Of Directors

BlueRock Therapeutics

Founding Board Member

Ghent University

, and

Member Board of Directors

Kronos Bio

BlueRock Therapeutics Member Board Of DirectorsJun 2022
Ghent University Founding Board MemberNov 2021
Kronos Bio Member Board of DirectorsJan 2021
Asklepios BioPharmaceutical Member Board of Directors ( A bayer company )Nov 2020
Arrowhead Pharmaceuticals Member Board of DirectorsDec 2019
Gladstone Institutes Member Board of Directors, Gladstone FoundationSep 2017

Related Hubs

Hub Name	CB Rank (Hub)
Therapeutics Public Companies With Less Than $500M in Revenue	40,661
Bill & Melinda Gates Foundation Portfolio Companies	73,422
California Public Companies With Less Than $500M in Revenue	36,601
San Francisco Bay Area Public Companies With Less Than $1B in Revenue	100,251
San Francisco Bay Area Biotechnology Companies	28,902
Therapeutics Public Companies With More Than 10 Employees	40,914
Therapeutics Public Companies With Less Than $1B in Revenue	41,829
Therapeutics Companies With More Than $10M in Revenue	22,743
Western US Health Care Public Companies	64,414
San Francisco Bay Area Therapeutics Companies	45,386

Education

Marianne De Backer

studied at

Ghent University

Vrije Universiteit Brussel

, and

Ghent University

Ghent University Master's DegreeEngineering, Engineering/Biochemistry19871991
Vrije Universiteit Brussel Master's DegreeMolecular Biology & Biotechnology19921994
Ghent University PhDBiotechnology19982001
George Washington University Board certification20162016
Harvard Business School 20172017